Drug Profile
Ropinirole implant - Titan Pharmaceuticals
Alternative Names: Ropinirole hydrochloride implant - Titan Pharmaceuticals; Ropinirole hydrochloride/ethylene vinyl acetate - Titan PharmaceuticalsLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Titan Pharmaceuticals
- Class Amines; Antiparkinsonians; Indoles; Sleep disorder therapies; Small molecules
- Mechanism of Action Dopamine D2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Parkinson's disease
Most Recent Events
- 30 Mar 2020 Discontinued - Phase-I/II for Parkinson's disease in USA (SC)
- 07 Sep 2017 Chemical structure information added
- 30 Aug 2017 Titan receives SBIR grant from the National Institute of Neurological Disorders and Stroke for long-term, non-fluctuating dopamine agonist development in Parkinson′s disease